Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 51151-51200 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05810064
Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)
N/A
Recruiting
30,000 participants
Started: Feb 22, 2022 · Completed: Aug 31, 2026
1 condition
2 sponsors
3 locations
NCT05846685
Patient Perspectives of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)
N/A
Recruiting
174 participants
Started: Feb 22, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
3 locations
NCT05451979
HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)
NA
Recruiting
10 participants
Started: Feb 22, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05145491
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
NA
Recruiting
400 participants
Started: Feb 22, 2022 · Completed: Dec 31, 2026
1 condition
4 sponsors
45 locations
NCT04665037
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
PHASE2
Recruiting
40 participants
Started: Feb 22, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
26 locations
NCT06217809
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
NA
Recruiting
552 participants
Started: Feb 22, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05120804
Family Functioning in Obesity Treatment for Mexican Americans
NA
Recruiting
236 participants
Started: Feb 22, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
2 locations
NCT06132009
Predictive Value of Preoperative Evaluation in Cases of Recurrent Endometriosis
N/A
Recruiting
64 participants
Started: Feb 22, 2022 · Completed: Feb 1, 2024
1 condition
1 sponsor
1 location
NCT05302271
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
PHASE1
Recruiting
25 participants
Started: Feb 22, 2022 · Completed: Dec 31, 2029
4 conditions
2 sponsors
1 location
NCT04992624
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
PHASE2
Recruiting
200 participants
Started: Feb 22, 2022 · Completed: Oct 31, 2026
2 conditions
3 sponsors
1 location
NCT05286905
FEA, Biomechanical and Clinical Study of R.O. Peritrochanteric Fractures With PFLP vs Cephalomedullary Nail.
NA
Recruiting
30 participants
Started: Feb 22, 2022 · Completed: Feb 22, 2026
1 condition
1 sponsor
1 location
NCT04731519
Development of a Recovery Oriented Treatment for Post-Acute Suicidal Episode (PASE) Veterans
NA
Recruiting
57 participants
Started: Feb 22, 2022 · Completed: Apr 25, 2026
1 condition
1 sponsor
1 location
NCT05027737
Early Ileostomy Closure for Rectal Cancer Patients in North America
NA
Recruiting
118 participants
Started: Feb 22, 2022 · Completed: Sep 1, 2026
2 conditions
2 sponsors
4 locations
NCT04936074
Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy
NA
Recruiting
300 participants
Started: Feb 21, 2022 · Completed: Feb 1, 2033
1 condition
4 sponsors
1 location
NCT05316389
Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life
N/A
Recruiting
200 participants
Started: Feb 21, 2022 · Completed: Feb 21, 2025
1 condition
1 sponsor
1 location
NCT05248763
Taiwan Cancer Moonshot Project
N/A
Recruiting
4,190 participants
Started: Feb 21, 2022 · Completed: Dec 31, 2035
1 condition
2 sponsors
1 location
NCT05767242
Early Neurophysiological Markers of Language Impairments
N/A
Recruiting
100 participants
Started: Feb 21, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT04917328
Compression Ultrasonography in Non-high Probability of Deep Vein Thrombosis
NA
Recruiting
700 participants
Started: Feb 21, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT05051033
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
NA
Recruiting
450 participants
Started: Feb 21, 2022 · Completed: Nov 15, 2030
1 condition
2 sponsors
61 locations
NCT05961969
Robotic Top-down Intersphincteric Resection
N/A
Recruiting
40 participants
Started: Feb 21, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05224518
Exercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer
NA
Recruiting
106 participants
Started: Feb 21, 2022 · Completed: Dec 31, 2027
3 conditions
2 sponsors
1 location
NCT05208684
Prolactin Release Through Breast Stimulation in Non-lactating Women - Who Does Respond?
NA
Recruiting
40 participants
Started: Feb 21, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04258488
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
PHASE4
Recruiting
1,300 participants
Started: Feb 21, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
11 locations
NCT05002816
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
PHASE1/PHASE2
Recruiting
24 participants
Started: Feb 21, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05116072
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
PHASE1/PHASE2
Recruiting
36 participants
Started: Feb 20, 2022 · Completed: Feb 20, 2030
3 conditions
2 sponsors
1 location
NCT05183243
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
PHASE1
Recruiting
68 participants
Started: Feb 20, 2022 · Completed: Feb 20, 2025
5 conditions
1 sponsor
9 locations
NCT05242861
Retrospective Study of Brachytherapy
N/A
Recruiting
300 participants
Started: Feb 20, 2022 · Completed: Dec 31, 2027
7 conditions
1 sponsor
1 location
NCT05254041
Pilot Study of Suction as a Mechanism of IUD Expulsion With Concomitant Menstrual Cup Use
NA
Recruiting
80 participants
Started: Feb 20, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04232566
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
N/A
Recruiting
60 participants
Started: Feb 20, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05176379
Endothelial Derived Hyperpolarization Factor and Vascular Control
PHASE4
Recruiting
30 participants
Started: Feb 19, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05669105
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research
N/A
Recruiting
200 participants
Started: Feb 19, 2022 · Completed: Mar 31, 2024
1 condition
1 sponsor
1 location
NCT05281757
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex
N/A
Recruiting
200 participants
Started: Feb 18, 2022 · Completed: Oct 31, 2028
5 conditions
2 sponsors
2 locations
NCT04851613
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
PHASE3
Recruiting
256 participants
Started: Feb 18, 2022 · Completed: Dec 30, 2026
1 condition
1 sponsor
55 locations
NCT05211895
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
PHASE3
Recruiting
860 participants
Started: Feb 18, 2022 · Completed: Sep 12, 2030
1 condition
2 sponsors
260 locations
NCT05269589
Home-based Heat Therapy for Type 2 Diabetes
NA
Recruiting
44 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05329727
The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF
N/A
Recruiting
1,000,000 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04957095
Motor Network Physiology
NA
Recruiting
120 participants
Started: Feb 18, 2022 · Completed: Dec 1, 2028
2 conditions
3 sponsors
1 location
NCT05027906
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
PHASE1/PHASE2
Recruiting
48 participants
Started: Feb 18, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
9 locations
NCT05450822
Precision Medicine in the Treatment of Epilepsy
N/A
Recruiting
550 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2031
1 condition
1 sponsor
1 location
NCT05203224
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
PHASE2
Recruiting
300 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT05141877
Influences of Propofol and Sevoflurane Anesthesia in Brain Tumor
PHASE4
Recruiting
706 participants
Started: Feb 18, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05145400
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
PHASE2
Recruiting
50 participants
Started: Feb 18, 2022 · Completed: Mar 1, 2031
2 conditions
2 sponsors
5 locations
NCT05168930
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
PHASE2
Recruiting
45 participants
Started: Feb 18, 2022 · Completed: Oct 28, 2028
2 conditions
2 sponsors
4 locations
NCT04971720
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
PHASE2/PHASE3
Recruiting
160 participants
Started: Feb 18, 2022 · Completed: Jan 1, 2027
6 conditions
2 sponsors
1 location
NCT06102070
Genetic Susceptibility to Severe Infections
N/A
Recruiting
2,000 participants
Started: Feb 18, 2022 · Completed: Oct 18, 2038
1 condition
1 sponsor
1 location
NCT05138393
Scoliosis-specific Exercises for Mild Idiopathic Scoliosis
NA
Recruiting
90 participants
Started: Feb 18, 2022 · Completed: Nov 30, 2037
1 condition
2 sponsors
2 locations
NCT05150652
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
PHASE2
Recruiting
70 participants
Started: Feb 18, 2022 · Completed: Oct 31, 2036
4 conditions
1 sponsor
1 location
NCT05247138
Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
N/A
Recruiting
142 participants
Started: Feb 18, 2022 · Completed: Jul 1, 2029
1 condition
3 sponsors
11 locations
NCT05190705
Loncastuximab Tesirine in WM
PHASE2
Recruiting
36 participants
Started: Feb 17, 2022 · Completed: Aug 1, 2028
1 condition
2 sponsors
4 locations
NCT05299138
Restoring Empowerment and Choosing Hope (REACH)
NA
Recruiting
900 participants
Started: Feb 17, 2022 · Completed: Jun 1, 2025
2 conditions
1 sponsor
1 location
Previous
1
More pages
1021
1022
1023
1024
1025
1026
1027
More pages
1333
Next